Digital cardiac and lung disease health startup Eko Health announced it received FDA 510(k) clearance for its AI-enabled cardiac tool that helps with the early detection of low ejection fraction, a key indicator of heart failure.
Eko Low Ejection Fraction Tool (ELEFT), which officially received the green light from the FDA in March, is an AI-enabled tool that allows providers to detect low...
Lyfegen, which offers a platform for value-based contracting for high-cost drugs, announced it had raised $8 million in Series A funding.
The round was led by aMoon, with participation from APEX Ventures and other investors. The startup, which is headquartered in Switzerland and the U.S., offers software that aims to help pharma companies, payers, providers and medical technology companies adopt...
Smart stethoscope company Eko last week announced it has received FDA 510(k) clearance for an algorithm that detects and characterizes heart murmurs in adult and pediatric patients.
Eko Murmur Analysis Software, which officially received the green light in late June, is a machine learning algorithm that uses heart sounds, phonocardiograms and ECG signals (when available) to detect murmurs and...
Heart-health-focused startup Eko is launching a new version of its Eko app, which uses an AI algorithm to help detect heart disease. This news coincides with a $30 million Series C extension round to fuel commercialization and product development efforts, according to TechCrunch.
The new app can be paired with one of Eko's smart stethoscopes and is equipped with an AI software algorithm, which...
Edward Liu, a former head at Morgan Stanley, has joined medical-booking platform Zocdoc as its new chief financial officer.
Most recently, Liu served as Head of Americas Banking Technology at Morgan Stanley, where he advised CEOs, CFOs and boards on their strategic and financing decisions. He also previously spent time at McKinsey & Company and at Patricof & Co. Ventures.
In his new role...
This morning, digital cardiopulmonary health startup Eko pulled back the curtain on $65 million in new funding. The Series C raise was headed by Capital Partners and Questa Capital, and also saw participation from Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures and other investors.
WHAT IT DOES
Based in Oakland, California, Eko is known for combining ECG-enabled digital stethoscope devices...
Searching for outbreaks. The long and sometimes muddled tradition of predicting outbreak hot spots by analyzing search engine activity has continued into the COVID-19 era, with Mayo Clinic researchers publishing new findings that suggest strong correlations between certain keywords and case reports. In reviewing data from Jan. 22 to April 6, "face mask," "Lysol" and "COVID stimulus check" had the...
Cardio-focused digital health company Eko has inked a deal with AstraZeneca in order for the two to work together to develop digital health-screening tools.
According to the companies, the pharm giant will be looking to employ Eko’s AI-enabled algorithms in developing early detection tools, as well as to use the tech in clinical trials.
WHY IT MATTERS
Heart disease accounts for roughly one in...
Early this week cardiac-focused digital health company Eko scored a temporary Emergency Use Authorization (EUA) for its ECG low ejection fraction tool, which can be used to help clinicians spot cardiac complications associated with the novel coronavirus.
Providers are able to use the tool in order to get an assessment of Left Ventricular Ejection Fraction, a measure which providers can use to...
This morning digital cardiac health startup Eko announced that its atrial fibrillation and heart murmur detection algorithm landed a 510(k) FDA clearance. The new algorithms are designed to integrate with Eko’s stethoscope, which is already on the market, and be used by healthcare providers.
The company said it plans to add more algorithms in the future. Next up will be an ECG-based algorithm...
_4.jpg?itok=m5TIq4KA)
